<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jia J</submitter><funding>Intramural NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>75-85</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4834246</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>279</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Cytochrome P450 epoxygenases (CYP) metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs), which exhibit vasodilatory, anti-inflammatory and neuroprotective actions in experimental cerebral ischemia. We evaluated the effect of endothelial-specific CYP overexpression on cerebral blood flow, inflammatory cytokine expression and tissue infarction after focal cerebral ischemia in transgenic mice.&lt;h4>Approach and results&lt;/h4>Male and female wild-type and transgenic mice overexpressing either human CYP2J2 or CYP2C8 epoxygenases in vascular endothelium under control of the Tie2 promoter (Tie2-CYP2J2 and Tie2-CYP2C8) were subjected to 60-min middle cerebral artery occlusion (MCAO). Microvascular cortical perfusion was monitored during vascular occlusion and reperfusion u</pubmed_abstract><journal>Experimental neurology</journal><pubmed_title>Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.</pubmed_title><pmcid>PMC4834246</pmcid><funding_grant_id>R01GM088199</funding_grant_id><funding_grant_id>P01 NS049210</funding_grant_id><funding_grant_id>R01 HL093140</funding_grant_id><funding_grant_id>R01 GM088199</funding_grant_id><funding_grant_id>R01 NS044313</funding_grant_id><funding_grant_id>P01NS049210</funding_grant_id><funding_grant_id>R01 NS070837</funding_grant_id><funding_grant_id>R01HL093140</funding_grant_id><funding_grant_id>Z01 ES025034</funding_grant_id><funding_grant_id>R01NS070837</funding_grant_id><pubmed_authors>DeGraff LM</pubmed_authors><pubmed_authors>Davis CM</pubmed_authors><pubmed_authors>Graves JP</pubmed_authors><pubmed_authors>Lee CR</pubmed_authors><pubmed_authors>Jia J</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Zeldin DC</pubmed_authors><pubmed_authors>Alkayed NJ</pubmed_authors><pubmed_authors>Jia T</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Edin ML</pubmed_authors><pubmed_authors>Jouihan S</pubmed_authors><pubmed_authors>Ronnekleiv O</pubmed_authors><pubmed_authors>Bradbury JA</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.</name><description>&lt;h4>Objective&lt;/h4>Cytochrome P450 epoxygenases (CYP) metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs), which exhibit vasodilatory, anti-inflammatory and neuroprotective actions in experimental cerebral ischemia. We evaluated the effect of endothelial-specific CYP overexpression on cerebral blood flow, inflammatory cytokine expression and tissue infarction after focal cerebral ischemia in transgenic mice.&lt;h4>Approach and results&lt;/h4>Male and female wild-type and transgenic mice overexpressing either human CYP2J2 or CYP2C8 epoxygenases in vascular endothelium under control of the Tie2 promoter (Tie2-CYP2J2 and Tie2-CYP2C8) were subjected to 60-min middle cerebral artery occlusion (MCAO). Microvascular cortical perfusion was monitored during vascular occlusion and reperfusion u</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 May</publication><modification>2025-04-04T08:49:47.971Z</modification><creation>2019-06-06T15:43:00Z</creation></dates><accession>S-EPMC4834246</accession><cross_references><pubmed>26902473</pubmed><doi>10.1016/j.expneurol.2016.02.016</doi></cross_references></HashMap>